Search

Pooled testing is most efficient when applied in settings of low virus prevalence.

Due to early logistical planning, Rwanda had the capacity to store 5 million doses before the vaccines arrived.

To effectively control COVID-19 and prevent a future pandemic, Nigeria needs to start investing heavily in science research.

For the first time, the drug substance, or active ingredient for a COVID-19 vaccine - in this case mRNA - will be manufactured on the continent.

These results emphasise the high significance of the transport sector in Kigali’s air pollution levels and the need for further action to address air pollution from the sector.

Stricter measures had major impacts on farmers’ livelihoods and food security.

When the UK’s red list is considered at a more granular level, the difficulties become immediately apparent.

The global cost of lost productivity due to depression and anxiety disorders is jarring. Around 4.7 billion days of productivity a year are lost.

Moves by Moderna and BioNTech to make vaccines themselves in African countries signal that the companies aren’t considering licensing its technology to a third party for local manufacture.

The most sustainable and cost-effective solution for protecting patients’ lives is to reduce the causes of human error. Health professionals must be adequately trained to reduce adverse outcomes.